文献速递生殖医学

辅助卵母细胞激活显著提高胞浆内单精子注射后低受精及完全受精失败患者的受精与妊娠结局:一项17年回顾性研究

Assisted oocyte activation significantly increases fertilization and pregnancy outcome in patients with low and total failed fertilization after intracytoplasmic sperm injection: a 17-year retrospective study.
PubMed 文献 · Fertil Steril · 2019-05-24

该回顾性队列研究纳入122对胞浆内单精子注射(ICSI)后低受精或完全受精失败的夫妇,所有患者激活前均行小鼠卵母细胞激活试验(MOAT)。与既往243个ICSI周期相比,191个辅助卵母细胞激活(AOA)周期显著改善各MOAT组的受精、妊娠和活产率;AOA后共225次胚胎移植获得60例健康活产。作者认为AOA应保留给明确卵母细胞激活缺陷的患者。

要点

  • AOA较既往ICSI显著改善所有MOAT组的受精、妊娠和活产率。
  • MOAT 1组与3组妊娠率49.0% vs 29.4%、活产率41.2% vs 22.1%。
  • AOA后225次胚胎移植共获得60例健康活产。

核心结论

  • 在AOA前行诊断性检测的患者,其临床结局较既往周期显著改善。
  • 作者认为AOA应保留给明确卵母细胞激活缺陷的患者。

研究设计与样本

  • 回顾性队列研究,比较AOA周期与既往ICSI周期。
  • 共纳入122对有ICSI后低受精或完全受精失败史的夫妇;所有患者AOA前均行小鼠卵母细胞激活试验(MOAT)。
  • 研究在 university hospital 的不孕症中心进行,共17年。

主要发现

  • MOAT显示19例为精子相关卵母细胞激活缺陷(MOAT 1组)、56例为精子相关卵母细胞激活能力减弱(MOAT 2组)、47例为疑似卵母细胞相关卵母细胞激活缺陷(MOAT 3组)。
  • AOA(191个周期)较既往ICSI尝试(243个周期)显著改善所有MOAT组的受精率、妊娠率和活产率。
  • AOA后受精率在MOAT 1组(70.1%)、2组(63.0%)和3组(57.3%)间差异显著。
  • MOAT 1组与3组间妊娠率(49.0% vs 29.4%)和活产率(41.2% vs 22.1%)差异显著。
  • AOA后共225次胚胎移植获得60例健康活产。

临床怎么用

  • 作者认为AOA应保留给明确卵母细胞激活缺陷的患者。
  • 本研究中所有患者在AOA前均行MOAT检测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the extent to which assisted oocyte activation (AOA) improves clinical outcomes in patients diagnosed with oocyte activation deficiencies (OADs). DESIGN: Retrospective cohort study comparing AOA cycles and previous intracytoplasmic sperm injection (ICSI) cycles in couples experiencing low or total failed fertilization after ICSI. Importantly, the sperm-related oocyte-activating capacity was examined in all patients before AOA with the use of the mouse oocyte activation test (MOAT). SETTING: Infertility center at a university hospital. PATIENT(S): A total of 122 couples with a history of low or total failed fertilization after ICSI. INTERVENTION(S): ICSI, MOAT, AOA, and embryo transfer. MAIN OUTCOME MEASURE(S): Fertilization, pregnancy, and live birth rates. RESULT(S): MOAT revealed 19 patients with a sperm-related OAD (MOAT group 1), 56 patients with a diminished sperm-related oocyte-activating capacity (MOAT group 2), and 47 patients with a suspected oocyte-related OAD (MOAT group 3). AOA (191 cycles) significantly improved fertilization, pregnancy, and live birth rates in all MOAT groups compared with previous ICSI attempts (243 cycles). Fertilization rates after AOA were significantly different among MOAT groups 1 (70.1%), 2 (63.0%), and 3 (57.3%). Between MOAT group 1 and 3, significant differences in pregnancy (49.0% vs. 29.4%) and live birth (41.2% vs. 22.1%) rates were observed. In total, 225 embryo transfers resulted in 60 healthy live births following AOA. CONCLUSION(S): Patients undergoing diagnostic testing before AOA show a significant improvement in clinical outcomes compared with previous cycles. Our findings highlight that AOA should be reserved for patients with clear OADs.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Bonte D, Ferrer-Buitrago M, Dhaenens L, et al. Assisted oocyte activation significantly increases fertilization and pregnancy outcome in patients with low and total failed fertilization after intracytoplasmic sperm injection: a 17-year retrospective study. Fertil Steril. 2019. PMID: 31133387. doi:10.1016/j.fertnstert.2019.04.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。